Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-20 | Edmund P. Harrigan, M.D. INDEPENDENT DIRECTOR Age: 67 COMMITTEES: None DIRECTOR SINCE: 2019 Edmund P. Harrigan, M.D. joined the Board in December 2019. Dr. Harrigan served as Senior Vice President of Worldwide Safety and Regulatory for Pfizer Inc. |
| 2021-04-16 | Edmund P. Harrigan, M.D. joined the Board in December 2019. Dr. Harrigan served as Senior Vice President of Worldwide Safety and Regulatory for Pfizer Inc. from 2012 until his retirement in 2015. |
| 2022-04-29 | Edmund P. Harrigan, M.D. joined the Board in December 2019. Dr. Harrigan served as Senior Vice President of Worldwide Safety and Regulatory for Pfizer Inc. from 2012 until his retirement in 2015. Dr. Harrigan’s previous executive leadership roles at Pfizer included serving as Senior Vice President, Head of Worldwide Business Development, Senior Vice President, Head of Worldwide Regulatory Affairs and Quality Assurance, and Vice President, Head of Neuroscience and Ophthalmology. Previously, Dr. Harrigan served in senior leadership positions at Karuna Pharmaceuticals, Inc., Sepracor Inc., and Neurogen Corporation. Prior to entering the pharmaceutical industry in 1990, Dr. Harrigan was a practicing neurologist for seven years. The Board has concluded that Edmund P. Harrigan should serve on the Board because he has significant executive leadership experience in the pharmaceutical and biotechnology industry, including experience in drug discovery and development, regulatory affairs and business development. Dr. Harrigan also brings substantial medical and scientific experience to the Board. In addition, Dr. Harrigan has significant experience serving as a director of other publicly held life sciences companies. Other Public Company Boards: Current ACADIA Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc. Past 5 Years Bellicum Pharmaceuticals, Inc. (2018-2019) Karuna Therapeutics, Inc. (2011-2020) |
| 2023-04-28 | Edmund P. Harrigan, M.D., Independent Director, Former Senior Vice President of Worldwide Safety and Regulatory, Pfizer Inc., Age: 70, Director Since: 2019, Committees: Science and Technology (Chair), Audit and Finance, 2022 Director Compensation Table: Total $451,218 |
| 2024-04-29 | Edmund P. Harrigan, M.D. INDEPENDENT DIRECTOR Age: 71 COMMITTEES: Science and Technology (Chair), Audit and Finance DIRECTOR SINCE: 2019 |
Data sourced from SEC filings. Last updated: 2025-12-06